Specialized Nerve Stimulation Systems for High-Risk Environments
Legal Citation
Summary of the Inventive Concept
This inventive concept adapts the original coordinated trigeminal and vagal nerve stimulation method for reducing bleeding in specific, high-risk environments, such as high-altitude, disaster relief, extreme weather, and high-security settings, ensuring tailored solutions for unique operational needs.
Background and Problem Solved
The original patent disclosed a method and apparatus for reducing bleeding via coordinated trigeminal and vagal nerve stimulation. However, the original design may not be suitable for extreme environments, where additional considerations, such as low oxygen levels, waterproofing, and enhanced security, are crucial. This inventive concept addresses these limitations by introducing specialized variations and niche solutions for high-risk environments.
Detailed Description of the Inventive Concept
The inventive concept comprises a range of systems and methods that adapt the original coordinated nerve stimulation approach to specific high-risk environments. For instance, a system for reducing bleeding in high-altitude environments features a portable apparatus adapted to operate at low oxygen levels and extreme temperatures. Another embodiment includes a waterproof apparatus with GPS tracking for treating bleeding in patients during natural disasters. Other variations include a wearable device with a sensor for monitoring blood coagulation levels in patients with bleeding disorders, an apparatus with enhanced security features for high-security facilities, and a ruggedized apparatus for treating bleeding in extreme weather environments.
Novelty and Inventive Step
The new claims introduce novel adaptations of the original coordinated nerve stimulation method, tailored to specific high-risk environments. These adaptations, such as low-oxygen operation, waterproofing, and enhanced security, are non-obvious and provide a significant inventive step over the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include, but are not limited to, systems for reducing bleeding in patients with specific medical conditions, such as hemophilia, or in patients undergoing surgery in remote or resource-constrained areas. Other variations could include adapting the apparatus for use in space exploration or in areas with limited access to medical resources.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including emergency response, disaster relief, high-security facilities, and extreme environment exploration. The market for these specialized nerve stimulation systems is expected to grow as the need for tailored solutions in high-risk environments increases.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical electrical stimulation and nerve modulation technologies, focusing on non-invasive therapeutic interventions for physiological processes such as hemostasis and bleeding control
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in neurostimulation, electrical medical devices, and physiological response mechanisms, possessing knowledge of nerve stimulation techniques and environmental adaptation strategies for medical technologies
Obviousness Rationale
A person having ordinary skill in the art would recognize that the source patent's core method of coordinated trigeminal and vagal nerve stimulation for bleeding control represents a fundamental technique that can be readily adapted to various environmental and operational contexts. The PTD's variations represent predictable extensions of the original patent's core technological concept, applying known design modification principles to expand the utility of the nerve stimulation approach across different use scenarios.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,788 |
|---|---|
| Title | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
| Assignee(s) | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH |